| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology (Drs. Caselli and Whisnant) and Division of Rheumatology and Internal Medicine (Dr. Hunder), Mayo Clinic and Mayo Foundation, Rochester, MN.
Neurologic findings were studied in 166 consecutive patients with biopsy-proven giant cell (temporal) arteritis. Neurologic problems occurred in 51 patients (31%): neuropathies (23), TIA/strokes (12), neuro-otologic syndromes (11), tremor (6), neuropsychiatric syndromes (5), tongue numbness (3), and myelopathy (1). Neuro-ophthalmologic problems occurred in 35 patients (21%): amaurosis fugax (AF) (17), permanent vision loss (PVL) (14), scintillating scotoma (8), and diplopia (3). Abnormalities in large arteries in 52 patients (31%) included bruits and diminished pulses. The carotid artery was involved in 31 patients (bilateral in 58%). Overall, 35% of patients with carotid disease had TIA/stroke, AF, or PVL.
Address correspondence and reprint requests to Dr. Hunder, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Presented in part at the thirty-eighth annual meeting of the American Academy of Neurology, New Orleans, LA, April 1986.
Received April 3, 1987. Accepted for publication in final form June 4, 1987.
This article has been cited by other articles:
|
|
 |
|
  T. Loddenkemper, P. Sharma, I Katzan, and G. T Plant Risk factors for early visual deterioration in temporal arteritis J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1255 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Jordan and for the Expert Panel on Neurologic Imaging Headache AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1824 - 1826. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Nordborg and C. Nordborg Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment Rheumatology, March 1, 2003; 42(3): 413 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Roelcke, D. Eschle, L. Kappos, M. Moschopulos, R.H. Laeng, and U.W. Buettner Meningoradiculitis associated with giant cell arteritis Neurology, December 10, 2002; 59(11): 1811 - 1812. [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Collins, M. I. Periquet, K. de Groot, and E. Reinhold-Keller Prevalence of Vasculitic Neuropathy in Wegener Granulomatosis Arch Neurol, August 1, 2002; 59(8): 1333 - 1334. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Salvarani, F. Cantini, L. Boiardi, and G. G. Hunder Polymyalgia Rheumatica and Giant-Cell Arteritis N. Engl. J. Med., July 25, 2002; 347(4): 261 - 271. [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Hellmann Temporal Arteritis: A Cough, Toothache, and Tongue Infarction JAMA, June 12, 2002; 287(22): 2996 - 3000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Semmler, H. Urbach, and T. Klockgether Giant cell arteritis causing multiple vertebro-basilar infarcts Neurology, May 14, 2002; 58(9): 1399 - 1399. [Full Text] [PDF]
|
|
|
|
|
|
H. Staunton, F. Stafford, M. Leader, and D. O'Riordain Deterioration of Giant Cell Arteritis With Corticosteroid Therapy Arch Neurol, April 1, 2000; 57(4): 581 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Joelson, B. Ruthrauff, F. Ali, N. Lindeman, and F. R. Sharp Multifocal Dural Enhancement Associated With Temporal Arteritis Arch Neurol, January 1, 2000; 57(1): 119 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M Moore and B. Richardson Neurology of the vasculitides and connective tissue diseases J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 10 - 22. [Full Text]
|
|
|
|
 |
|
 P. Harten, B. Seyfarth, H. Loffler, M. A. Gonzalez-Gay, C. Garcia-Porrua, and M. Vazquez-Caruncho Thrombocytosis in Polymyalgia Rheumatica: An Additional Diagnostic Criterion and Possible Risk Factor for Ischemic Complications? Arch Intern Med, January 12, 1998; 158(1): 95 - 97. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
